Clinical Trial Update: Autologous Mesenchymal Stem Cell Transplantation in Cirrhosis Patients With Refractory Ascites [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating autologous mesenchymal stem cell transplantation for cirrhosis with refractory ascites; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ascites
• Cirrhosis of the Liver

Drugs mentioned

• Autologous mesenchymal stem cell transplantation (Mesenchymal stem cells)

Snippet

Sponsor: Nanjing PLA General Hospital | Conditions: Immune Function in Blood, Liver Function in Blood | Phase 3 | Status: UNKNOWN